Vicadrostat by Boehringer Ingelheim International for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval

Vicadrostat is under clinical development by Boehringer Ingelheim International and currently in Phase III for Chronic Kidney Disease (Chronic Renal Failure).

Calls for humanitarian pause to safeguard polio vaccination efforts in Gaza

Two rounds of a polio vaccination campaign are expected to be launched at the end of August and September 2024 across the Gaza Strip to

August 18, 2024

Laxxon Medical to Host a Fireside Chat at UBS Global Healthcare Conference – Biotech Investments

New York, 10/25/2024 / 11:00, EST/EDT – EQS Newswire – Laxxon Medical Laxxon Medical Corp., a leading pharma technology company in oral drug delivery, today

October 26, 2024

CareFirst BCBS Community Health Plan Maryland Launches Medicaid Member Program

What You Should Know: – Wider Circle, which builds peer-driven communities nationwide to help people improve their health and quality of life through trusted connections, announced

September 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.